Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Prev Med. 2020 Apr 1;135:106074. doi: 10.1016/j.ypmed.2020.106074

Longitudinal associations between susceptibility to tobacco use and the onset of other substances among U.S. youth

Marushka L Silveira a,b,*, Kevin P Conway a,1, Colm D Everard a,b, Hwa Y Sim a,b, Heather L Kimmel a, Wilson M Compton a
PMCID: PMC7233357  NIHMSID: NIHMS1585364  PMID: 32243937

Abstract

We examined whether tobacco susceptibility at Wave (W) 1 (2013–2014) predicts the onset of tobacco and other substances at W2 (2014–2015) among 5325 U.S. youth (12–17 years) never substance users at W1 in the Population Assessment of Tobacco and Health (PATH) Study. Tobacco susceptibility was based on curiosity, use intentions, and response to a best friend’s offer to use. Onset of use included past 12-month use of a specific substance or group of substances at W2 among those who had never used any substance at W1. Approximately, 31.3% of W1 youth were susceptible to tobacco use. W2 onset was 8.2% (SE = 0.4) for alcohol exclusively, 5.0% (SE = 0.4) for polysubstance including tobacco, 4.4% (SE = 0.3) for tobacco exclusively, 3.1% (SE = 0.3) for other drugs (misused prescription stimulants and painkillers, cocaine, other stimulants, heroin, inhalants, solvents and hallucinogens) exclusively, 1.4% (SE = 0.2) for polysubstance excluding tobacco, and 0.9% (SE = 0.1) for marijuana exclusively. Tobacco-susceptible compared with non-tobacco susceptible youth had higher odds of onset of exclusive tobacco use (AOR: 2.4; 95% CI: 1.7, 3.3), exclusive alcohol use (AOR: 1.5; 95% CI: 1.2, 1.8), and polysubstance use (AOR: 3.9; 95% CI: 2.8, 5.6 including tobacco and AOR: 1.8; 95% CI: 1.1, 3.0 excluding tobacco) compared with W2 never substance use. In this national study, tobacco susceptibility identified U.S. youth at risk for onset of tobacco and other substances, perhaps reflecting common etiology and clustering of substance use in youth. Identifying and preventing tobacco-susceptible youth from progressing to using addictive substances must remain a public health priority.

Keywords: Susceptibility, Tobacco use, Vaping, Drug misuse, Marijuana use, Prevention, Adolescent

1. Introduction

Substance (tobacco, alcohol, and drug) use among U.S. youth (12–17 years) remains a major public health problem. For most substance users, initial use occurs early in adolescence (National Center for Chronic Disease Prevention and Health Promotion and Office on Smoking and Health, 2012; U.S. Department of Health and Human Services (HHS) and Office of the Surgeon General, 2016). This is concerning as youth who try substances are more likely to progress to regular use, dependence, and disorders in adulthood (Hall et al., 2016). Furthermore, early initiation, substance use, and substance use disorders are associated with several immediate and long-term negative physical, mental, social, and economic consequences (National Center for Chronic Disease Prevention and Health Promotion and Office on Smoking and Health, 2012; U.S. Department of Health and Human Services (HHS) and Office of the Surgeon General, 2016). Although tremendous progress has been made in the development of evidence-based prevention programs and policies for youth substance use (National Center for Chronic Disease Prevention and Health Promotion and Office on Smoking and Health, 2012; U.S. Department of Health and Human Services (HHS) and Office of the Surgeon General, 2016), sustained efforts are still needed to identify and prevent use across all substances among youth at risk.

Pierce et al.’s susceptibility to smoking index is a validated 3-item instrument that predicts the risk of cigarette smoking initiation several years before first use (Pierce et al., 1996). This index assessed both intentions to smoke and self-efficacy about refusing a cigarette and was expanded to include curiosity (Nodora et al., 2014; Strong et al., 2015). Pierce’s index has also been found to predict risk for tobacco product use other than cigarettes (Pierce et al., 2018). Given the co-occurring use of tobacco, alcohol, and drugs (Conway et al., 2018; Richter et al., 2017; Silveira et al., 2018; Silveira et al., 2019) possibly due to shared vulnerability to use these substances (Vanyukov et al., 2012) and clustering of problem behaviors (Jessor, 1991), youth susceptible to tobacco product use can also be at risk for initiating other substances.

A recent national study on U.S. youth, found that those who were susceptible to e-cigarettes had greater odds of onset of e-cigarettes, alcohol, and marijuana use at follow up (Nicksic and Barnes, 2019). However, this study focused on e-cigarette susceptibility only, excluded drugs besides marijuana, and did not examine polysubstance use. To investigate whether susceptibility to tobacco use can potentially be used to identify youth at risk for initiating substances other than tobacco, we conducted a prospective study of susceptibility to tobacco use among never substance users as a longitudinal predictor of substance use onset across tobacco products, alcohol, marijuana, and other drugs (misused prescription stimulants and painkillers, cocaine and other stimulants, heroin, inhalants, solvents and hallucinogens) in the Population Assessment of Tobacco and Health (PATH) Study, an ongoing, nationally-representative, longitudinal study of adults and youth in the U.S. Consistent with a framework of common underlying risk for substance use, we hypothesized that susceptibility to tobacco use will predict the onset of substance use generally and across specific substances.

2. Methods

2.1. Study population

The current study included data from Wave (W) 1 and W2 of the PATH Study. Of the 13,651 youth (12 to 17 years) who completed the youth interview at W1, 11,996 completed the W2 interview (average follow-up period: 52 weeks), including 10,081 youth (12 to 17 years at W2) and 1915 aged-up adults (18+ years at W2) who completed the W2 youth and adult interviews, respectively. Analyses were further restricted to 5325 W1 never substance users (defined as self-reported never users of tobacco products, alcohol, marijuana, and other drugs) with data on variables of interest.

Details regarding the PATH Study design and methods are published elsewhere (Hyland et al., 2017) and available at https://doi.org/10.3886/ICPSR36231.v19. Briefly, a four-stage stratified address-based area-probability sampling design was used at W1 that oversampled adult tobacco users, young adults (18 to 24 years), and African-American adults. At W1, the weighted response rate for the household screener was 54.0%. Among households that were screened, the overall youth weighted response rate was 78.4%. Conditional on W1 participation, weighted response rates for the youth and adult interviews were 87.3% and 83.2% at W2. The W1 weighting procedures adjusted for differential probabilities of selection and nonresponse allowing estimates to be representative of the U.S. civilian, noninstitutionalized population. At W2, after adjusting for nonresponse, additional adjustments were made to protect against potential bias from attrition. Consent was obtained from parents, emancipated youth, and adults and assent was obtained from youth. Audio computer-assisted self-Inter-views (ACASI) available in English and Spanish were used to collect self-reported information on tobacco-use patterns and associated health behaviors at W1 and W2. This study was conducted by Westat and approved by Westat’s Institutional Review Board.

2.2. Measures

2.2.1. Susceptibility to tobacco use

Susceptibility to tobacco use was assessed using Pierce et al.’s 3-item measure of susceptibility (Pierce et al., 2018; Pierce et al., 2017; Trinidad et al., 2017). At W1, never users of 12 tobacco products (cigarettes, e-cigarettes, traditional cigars, cigarillos, filtered cigars, pipe, hookah, snus pouches, smokeless tobacco excluding snus pouches, dissolvable tobacco, bidis and kreteks) were asked: “Have you ever been curious about using < product >?”; “Do you think you might try using < product > soon?”; and “If one of your best friends were to offer you < product >, would you use it?”. The four-level response options for items ranged from “not at all curious” to “very curious” or from “definitely not” to “definitely yes”. The index was internally consistent among W1 youth in the PATH Study (Cronbach’s α = 0.82). Consistent with prior research (Pierce et al., 2018; Pierce et al., 2017; Trinidad et al., 2017), participants with the strongest rejection (i.e. “not at all curious” and “definitely not”) to all three questions for all products and those who had never heard of a product were classified as not susceptible. All others were considered susceptible to use ≥1 products, including those with missing responses (participants who endorsed don’t know or refused) based on the approach by Trinidad and colleagues, because their responses suggest that they have not endorsed a strong commitment not to use a tobacco product (Trinidad et al., 2017).

2.2.2. Onset of substance use

At W1, participants were asked whether they had ever used the following tobacco products: cigarettes, e-cigarettes, traditional cigars, cigarillos, filtered cigars, pipe, hookah, snus pouches, smokeless tobacco excluding snus pouches, dissolvable tobacco, bidis and kreteks. At W2, past 12-month use of the same tobacco products was assessed in the youth (12–17) and adult (18+) interviews; except bidis and kreteks that were not assessed in the adult interview. As data for these tobacco products were not available for youth who turned 18 years at W2, W2 tobacco use was defined as past 12-month use of any tobacco product except bidis and kreteks. Similarly, participants reported W1 ever use and W2 past 12-month use of alcohol, marijuana (including blunts), and other drugs (i.e. non-prescribed use of Ritalin® or Adderall®, painkillers, sedatives, or tranquilizers, and cocaine or crack, other stimulants (i.e. methamphetamine or speed), heroin, inhalants, solvents, and halluci-nogens). Items were adapted from the National Epidemiologic Survey on Alcohol and Related Conditions (National Institutes of Health (NIH), 2004–2005) and the National Health and Nutrition Examination Survey (Centers for Disease Control and Prevention (CDC), 2011–2012).

Four onset of use variables were created for tobacco, alcohol, marijuana, and other drugs and defined as past 12-month use of that specific substance or group of substances at W2 among never substance users at W1. Further, to examine differences by exclusive and polysubstance use, a 7-category onset of substance use variable was sub-sequently created as follows: (1) never use, (2) exclusive tobacco use, (3) exclusive alcohol use, (4) exclusive marijuana (including blunts) use, (5) exclusive other drug use, (6) polysubstance use including tobacco, and (7) polysubstance use excluding tobacco. Polysubstance use including tobacco was defined as any past 12-month use of two or more of the following: tobacco, alcohol, marijuana, and other drugs; whereas polysubstance use excluding tobacco was defined as any past 12-month use of two or more of the following: alcohol, marijuana, and other drugs.

2.2.3. Covariates

At W1, youth self-reported their sex, age, and race/ethnicity. Tobacco product user in the household (yes, no) was derived from youths’ responses regarding whether a household member used cigarettes, smokeless tobacco, such as chewing tobacco, snuff, dip, or snus, cigars, cigarillos, or filtered cigars, or any tobacco product. Additionally, youth were asked about the number of hours during the past seven days they were around others who were smoking including time at home, in a car, at school, or outdoors. Youth exposure to any smoking (home, car, at school, or outdoors) was categorized as yes vs. no. Academic performance was based on parents’ responses regarding their child’s grades at school in the past 12 months and categorized as at or above average (C grades and higher) and below average (below Cs). Emancipated youth self-reported their academic performance. Parents also reported their personal educational attainment and marital status.

Receptivity to tobacco product advertising, associated with onset of tobacco use (Pierce et al., 2018), was also assessed. Participants were asked to select the brand of their favorite tobacco advertisement from a list of 20 ads randomly sampled from a near-census collection (n = 959) of print, direct mail, and television ads used in the period immediately preceding the wave. For each ad shown, participants were asked if they had seen the ad in the past 12 months and whether they liked, disliked, or were neutral to the ad. Receptivity to ads was categorized as any receptivity (recalled an ad but did not like or have a favorite ad, liked or indicated a favorite ad, or liked and indicated a favorite ad) versus no receptivity (did not recall, like, or indicate a favorite ad) (Pierce et al., 2018; Pierce et al., 2017).

Sensation seeking, a risk factor for substance use (Hoyle et al., 2002), was assessed via three modified items from the Brief Sensation Seeking Scale. Response options for each item were summed to create a mean score (Conway et al., 2018). The scale was internally consistent among W1 youth in the PATH Study (Cronbach’s α = 0.76). Lifetime mental health problems were assessed via the internalizing and externalizing subscales of the Global Appraisal of Individual Needs – Short Screener (GAIN-SS) (Dennis et al., 2006), modified for the PATH Study and categorized into no/low (0–2 symptoms), moderate (3–7 symptoms), or high (8–11 symptoms) severity based on prior research (Conway et al., 2018).

2.3. Statistical analysis

Distributions of susceptibility to tobacco use, onset of substance use, and covariates were examined. Sex, age, and race/ethnicity were imputed as described in the PATH Study Restricted Use Files User Guide (United States Department of Health and Human Services et al., 2020). Logistic regression was used to compute odds ratios (OR) and 95% confidence intervals (CI) separately for five onset of use outcomes: tobacco (yes, no), alcohol (yes, no), marijuana (yes, no), other drugs (yes, no), and the seven-category substance use outcome (never use, exclusive tobacco use, exclusive alcohol use, exclusive marijuana (including blunts) use, exclusive other drug use, polysubstance use including tobacco, and polysubstance use excluding tobacco). Covariates included factors previously found to be associated with substance use such as sociodemographic factors (age, sex, and race/ethnicity (Stone et al., 2012; Wellman et al., 2016)), parent’s marital status and educational attainment (Stone et al., 2012; Wellman et al., 2016), academic performance (National Center for Chronic Disease Prevention and Health Promotion and Office on Smoking and Health, 2012; Stone et al., 2012; Tomczyk et al., 2016; Wellman et al., 2016), sensation seeking (Hoyle et al., 2002; Wellman et al., 2016), exposure to tobacco use (tobacco product use in household (Wellman et al., 2016), exposure to any smoking (Wellman et al., 2016), receptivity to tobacco product advertising (National Center for Chronic Disease Prevention and Health Promotion and Office on Smoking and Health, 2012; Wellman et al., 2016)), and lifetime mental health problems at Wave 1 (Green et al., 2018; Stone et al., 2012). Parent’s marital status and educational attainment and youth’s exposure to any smoking were not significant in the adjusted models and therefore excluded from the final models. All covariates were analyzed as categorical variables except for sensation seeking which was analyzed continuously such that the ORs re-presented a one-unit increase in the mean score.

Estimates were weighted to represent the U.S. youth population; variances and CIs were estimated using the balanced repeated replication method (McCarthy, 1969) with Fay’s adjustment set to 0.3 to increase estimate stability (Judkins, 1990). W2 longitudinal weights were used in the analyses (United States Department of Health and Human Services et al., 2020). Estimates were flagged for low statistical precision if they were based on a denominator sample size of fewer than 50, or the coefficient of variation of the estimate or its complement was larger than 30% (Klein et al., 2002). All analyses were conducted on the Restricted use Files (United States Department of Health and Human Services et al., 2020) using SAS Survey Procedures, version 9.4 (SAS Institute Inc., Cary, NC).

3. Results

Demographic characteristics are presented in Table 1. Approximately one third (31.3%) of youth never substance users at W1 were susceptible to tobacco use. In unadjusted models, higher sensation seeking, older age, non-Hispanic Black and Hispanic race/ethnicity were positively associated with susceptibility to tobacco use. Female youth had lower odds of susceptibility to tobacco use compared to male youth. In addition, youth who had unmarried parents, had moderate and high severity lifetime mental health problems, had below average grades, lived with a tobacco product user, were exposed to any smoking, or had higher receptivity to tobacco advertising had higher odds of susceptibility to tobacco use in W1 compared to their counterparts.

Table 1.

Selected characteristics by susceptibility to tobacco use among W1 youth never substance users (n = 5325).

Wave 1 susceptibility to tobacco use

Total No Yes



na %b SEb na %b SEb na %b SEb ORc 95% CIc
Total 3616 68.7 0.6 1709 31.3 0.6
Sensation seekingd N/A N/A N/A 2.1 1.9 2.3
Age (years)
 12–14 3402 63.2 0.7 2392 71.1 0.8 1010 28.9 0.8 Referent
15–17 1923 36.8 0.7 1224 64.6 1.1 699 35.4 1.1 1.3 1.2 1.6
Gender
 Male 2803 52.5 0.4 1862 67.0 1.0 941 33.0 1.0 Referent
 Female 2522 47.5 0.4 1754 70.6 1.0 768 29.4 1.0 0.8 0.7 1.0
Race/ethnicity
 Non-Hispanic, White 2423 51.5 0.6 1758 72.1 0.9 665 27.9 0.9 Referent
 Non-Hispanic, Black 786 14.9 0.4 491 62.6 1.7 295 37.4 1.7 1.5 1.3 1.8
 Non-Hispanic, othere 463 9.5 0.3 308 70.9 2.2 155 29.1 2.2 1.1 0.8 1.4
 Hispanic 1653 24.1 0.4 1059 64.3 1.2 594 35.7 1.2 1.4 1.3 1.6
Parent educational attainment
 Up to 8th grade 398 5.9 0.4 272 69.2 2.4 126 30.8 2.4 Referent
 HS, no diploma 785 13.1 0.6 529 68.7 1.4 256 31.3 1.4 1.0 0.8 1.3
 HSD or GED 970 17.6 0.7 629 65.8 1.6 341 34.2 1.6 1.2 0.9 1.5
 Some college or more 3155 63.4 1.1 2174 69.4 0.8 981 30.6 0.8 1.0 0.8 1.3
Parent current marital status
 Married 3469 65.5 0.9 2435 71.1 0.7 1034 28.9 0.7 Referent
 Unmarried 1848 34.5 0.9 1178 64.4 1.1 670 35.6 1.1 1.4 1.2 1.5
Lifetime mental health problemsf
 No/low severity 1774 33.5 0.9 1433 81.2 1.0 341 18.8 1.0 Referent
 Moderate severity 2320 43.2 0.7 1560 68.2 1.0 760 31.8 1.0 2.0 1.7 2.4
 High severity 1231 23.3 0.7 623 51.7 1.4 608 48.3 1.4 4.0 3.4 4.8
Academic performanceg
 At or above average 4817 90.9 0.5 3321 69.6 0.6 1496 30.4 0.6 Referent
 Below average 508 9.1 0.5 295 59.6 2.7 213 40.4 2.7 1.6 1.2 2.0
Tobacco product user in household
 No 3828 72.9 1.1 2691 71.2 0.7 1137 28.8 0.7 Referent
 Yes 1497 27.1 1.1 925 62.1 1.3 572 37.9 1.3 1.5 1.3 1.7
Exposed to any smoking (home, car, school, outdoors)
 No 3620 69.7 0.9 2616 73.1 0.7 1004 26.9 0.7 Referent
 Yes 1590 30.3 0.9 913 58.1 1.3 677 41.9 1.3 2.0 1.7 2.3
Receptivity to tobacco advertising
 No 3116 59.3 0.9 2338 76.0 0.8 778 24.0 0.8 Referent
 Yes 2209 40.7 0.9 1278 58.1 1.2 931 41.9 1.2 2.3 2.0 2.6

Statistically significant associations at p < .05 indicated in bold text.

a

n represents unweighted sample sizes.

b

Percents (%) and standard errors (SEs) represent weighted estimates.

c

Odds ratios (ORs) and 95% confidence intervals (CIs) from unadjusted logistic regression models.

d

Measured via the modified Brief Sensation Seeking Scale.

e

Includes non-Hispanic American Indian/Alaska Natives, Asian/Native Hawaiian/Other Pacific Islanders, or multiple races.

f

Assessed via the Global Appraisal of Individual Needs-Short Screener (GAIN-SS) subscales, categorized into no/low (0–2 symptoms), moderate severity (3–7 symptoms) and high severity (8–11 symptoms).

g

Academic performance was based on parents’ responses regarding their child’s (or self-reported in case of emancipated youth) grades at school in the past 12 months and categorized as at or above average (C grades and higher) and below average (below Cs).

Among W1 youth never substance users, 23% began using at least one substance (i.e. tobacco products, alcohol, marijuana, or other drugs) at W2 (Table 2). Onset of exclusive alcohol use was the highest at 8.2% (SE = 0.4), followed by 5.0% (SE = 0.4) for polysubstance use including tobacco, 4.4% (SE = 0.3) for exclusive tobacco use, 3.1% (SE = 0.3) for exclusive other drug use, 1.4% (SE = 0.2) for polysubstance use excluding tobacco, and 0.9% (SE = 0.1) for exclusive marijuana use. In unadjusted models, sensation seeking, age, sex, race/ethnicity, parent’s marital status, lifetime mental health problems, academic performance, tobacco product user in the household, exposure to smoking, and receptivity to tobacco advertising were each associated with onset of substance use compared to never use.

Table 2.

Selected characteristics by substance use onset among W1 youth never substance users (n = 5325).

Wave 2 onset of substance use
Never usea Exclusive tobacco useb Exclusive alcohol use Exclusive marijuana usec




Wave 1 ng %h SEh ng %h SEh ORi 95% CIi ng %h SEh ORi 95% CIi ng %h SEh ORi
Total 4090 77.0 0.7 246 4.4 0.3 422 8.2 0.4 53 0.9 0.1
Sensation seekingj N/A N/A 1.4 1.1 1.7 1.4 1.6 1.5
Age (years)
 12–14 2722 80.3 0.8 138 3.8 0.3 Referent 231 7.0 0.5 Referent 31 0.8 0.1 Referent
 15–17 1368 71.3 1.2 108 5.3 0.5 1.6 1.2 2.1 191 10.2 0.8 1.6 2.1 22 1.0 0.2 1.4
Gender
 Male 2185 78.0 0.9 162 5.4 0.4 Referent 186 7.0 0.5 Referent 26 0.8 0.2 Referent
 Female 1905 75.9 1.0 84 3.2 0.4 0.6 0.5 0.8 236 9.5 0.7 1.4 1.8 27 0.9 0.2 1.2
Race/ethnicity
 Non-Hispanic, White 1874 77.5 1.0 103 4.0 0.4 Referent 228 9.5 0.7 Referent 10 0.4n 0.1 Referent
 Non-Hispanic, Black 602 76.4 1.7 36 4.6 0.8 1.2 0.8 1.8 43 5.4 0.9 0.6 0.8 19 2.4 0.6 6.1
 Non-Hispanic, otherk 350 78.6 2.3 18 2.6 0.7 0.6 0.4 1.1 41 8.4 1.4 0.9 1.3 8 1.0n 0.3 2.4
 Hispanic 1264 75.7 1.3 89 5.6 0.7 1.4 1.0 2.1 110 7.1 0.6 0.8 1.0 16 0.9 0.2 2.2
Parent educational attainment
 Up to 8th grade 314 78.5 2.3 19 5.0 1.1 Referent 23 6.2 1.4 Referent 5 1.1n 0.5 Referent
 HS, no diploma 588 74.5 1.7 53 7.4 1.2 1.6 0.9 2.8 43 5.5 1.0 0.9 1.8 10 1.2n 0.4 1.2
 HSD or GED 731 75.3 1.4 53 5.4 0.6 1.1 0.7 1.9 69 7.3 0.9 1.2 2.1 16 1.4 0.4 1.3
 Some college or more 2442 77.8 0.9 121 3.4 0.3 0.7 0.4 1.2 287 9.2 0.7 1.5 2.6 22 0.6 0.1 0.6
Parental marital status
 Married 2722 78.8 0.9 132 3.6 0.3 Referent 284 8.3 0.5 Referent 30 0.7 0.1 Referent
 Unmarried 1363 73.7 1.1 113 5.7 0.5 1.7 1.3 2.2 138 8.1 0.8 1.0 1.3 23 1.1 0.2 1.7
Lifetime mental health problemsl
 No/low severity 1470 82.5 0.9 64 3.6 0.5 Referent 99 5.8 0.6 Referent 20 0.9 0.2 Referent
 Moderate severity 1747 75.8 1.0 98 3.9 0.4 1.2 0.8 1.7 219 9.7 0.7 1.8 2.3 20 0.7 0.2 0.8
 High severity 873 71.4 1.5 84 6.4 0.7 2.0 1.4 2.9 104 8.8 1.0 1.8 2.4 13 1.0n 0.3 1.2
Academic performancem
 At or above average 3736 77.8 0.8 198 3.8 0.3 Referent 393 8.4 0.5 Referent 43 0.8 0.1 Referent
 Below average 354 68.9 2.1 48 10.1 1.4 3.0 2.1 4.3 29 5.8 1.1 0.8 1.2 10 1.8n 0.6 2.6
Tobacco product user in household
 No 3015 79.2 0.9 141 3.4 0.3 Referent 303 8.1 0.5 Referent 36 0.8 0.1 Referent
 Yes 1075 71.1 1.3 105 7.0 0.7 2.3 1.7 3.2 119 8.6 0.7 1.2 1.5 17 1.1 0.3 1.7
Exposed to any smoking (home, car, school, outdoors)
 No 2873 79.6 0.8 135 3.4 0.3 Referent 277 7.9 0.5 Referent 30 0.7 0.1 Referent
 Yes 1125 70.7 1.2 105 6.5 0.6 2.2 1.6 2.9 137 8.9 0.7 1.3 1.6 21 1.2 0.3 1.9
Receptivity to tobacco advertising
 No 2498 80.6 0.8 118 3.5 0.3 Referent 225 7.4 0.5 Referent 28 0.7 0.2 Referent
Yes 1592 71.7 1.3 128 5.6 0.6 1.8 1.3 2.5 197 9.4 0.7 1.4 1.8 25 1.0 0.2 1.5
Wave 2 onset of substance use
Exclusive
marijuana usec
Exclusive other drug used Poly-substance including tobacco usee Poly-substance excluding tobacco usef




Wave 1 95% CIi ng %h SEh ORi 95% CIi ng %h SEh ORi 95% CIi ng %h SEh ORi 95% CIi
Total 174 3.1 0.3 258 5.0 0.4 82 1.4 0.2
Sensation seekingj 1.0 2.1 1.1 0.9 1.4 1.9 1.6 2.2 1.3 1.0 1.7
Age (years)
 12–14 Referent 110 3.2 0.3 Referent 125 3.7 0.4 Referent 45 1.2 0.2 Referent
 15–17 0.9 2.4 64 3.0 0.4 1.1 0.8 1.5 133 7.4 0.7 2.3 1.8 2.8 37 1.8 0.3 1.7 1.1 2.7
Gender
 Male Referent 77 2.8 0.3 Referent 134 5.0 0.5 Referent 33 1.1 0.2 Referent
 Female 0.7 2.2 97 3.5 0.4 1.3 0.9 1.9 124 5.1 0.5 1.1 0.8 1.4 49 1.8 0.3 1.7 1.0 2.8
Race/ethnicity
 Non-Hispanic, White Referent 74 2.9 0.3 Referent 105 4.7 0.5 Referent 29 1.1 0.2 Referent
 Non-Hispanic, Black 2.6 14.2 29 3.8 0.8 1.3 0.8 2.3 43 5.4 0.9 1.2 0.8 1.8 14 2.0 0.6 1.9 1.0 3.7
 Non-Hispanic, otherk 1.0 5.6 21 3.7 0.8 1.3 0.8 2.1 18 3.9n 1.3 0.8 0.4 1.8 7 1.8n 0.9 1.6 0.5 5.5
 Hispanic 0.9 5.3 50 3.1 0.4 1.1 0.8 1.6 92 6.0 0.7 1.3 0.9 1.9 32 1.7 0.3 1.6 0.9 2.9
Parent educational attainment
 Up to 8th grade Referent 6 1.5n 0.7 Referent 21 5.7 1.2 Referent 10 2.1n 0.7 Referent
 HS, no diploma 0.4 3.9 35 4.0 0.7 2.8 0.9 8.5 41 5.5 0.9 1.0 0.6 1.8 15 1.8 0.5 0.9 0.4 2.1
 HSD or GED 0.4 4.4 31 3.2 0.6 2.3 0.8 6.7 56 5.9 0.9 1.1 0.6 1.9 14 1.4 0.4 0.7 0.3 1.7
 Some college or more 0.2 2.0 101 3.1 0.3 2.1 0.8 5.6 139 4.6 0.5 0.8 0.5 1.4 43 1.3 0.3 0.6 0.3 1.4
Parental marital status
 Married Referent 114 3.2 0.3 Referent 140 4.3 0.5 Referent 47 1.2 0.2 Referent
 Unmarried 1.0 3.1 59 3.0 0.4 1.0 0.7 1.4 117 6.4 0.6 1.6 1.2 2.2 35 1.9 0.4 1.8 1.1 2.9
Lifetime mental health problemsj
 No/low severity Referent 42 2.4 0.4 Referent 54 3.4 0.5 Referent 25 1.4 0.3 Referent
 Moderate severity 0.5 1.6 94 3.9 0.5 1.8 1.1 2.9 113 4.9 0.5 1.5 1.1 2.2 29 1.2 0.3 0.9 0.5 1.8
 High severity 0.5 2.9 38 2.8 0.4 1.4 0.8 2.3 91 7.7 0.9 2.6 1.7 3.9 28 2.0 0.4 1.6 0.9 2.9
Academic performancem
 At or above average Referent 159 3.2 0.3 Referent 215 4.6 0.4 Referent 73 1.4 0.2 Referent
 Below average 1.1 6.5 15 2.7 0.7 0.9 0.5 1.7 43 8.9 1.3 2.2 1.6 2.9 9 1.8n 0.6 1.5 0.7 3.0
Tobacco product user in household
 No Referent 132 3.3 0.3 Referent 152 4.1 0.4 Referent 49 1.2 0.2 Referent
 Yes 0.9 3.0 42 2.8 0.4 1.0 0.7 1.3 106 7.5 0.8 2.0 1.5 2.6 33 1.9 0.4 1.7 1.0 3.0
Exposed to any smoking (home, car, school, outdoors)
 No Referent 112 3.0 0.3 Referent 144 4.2 0.4 Referent 31 1.2 0.2 Referent
 Yes 1.0 3.4 58 3.4 0.4 1.3 0.9 1.8 113 7.4 0.7 2.0 1.6 2.6 49 1.9 0.4 1.8 1.1 3.0
Receptivity to tobacco advertising
 No Referent 92 2.8 0.3 Referent 115 3.8 0.4 Referent 40 1.2 0.2 Referent
Yes 0.8 2.9 82 3.7 0.4 1.5 1.0 2.2 143 6.8 0.7 2.0 1.5 2.7 42 1.7 0.3 1.6 1.0 2.5

Statistically significant associations at p < .05 indicated in bold text.

a

Reference group.

b

Refers to cigarettes, e-cigarettes, traditional cigars, cigarillos, filtered cigars, pipe, hookah, snus pouches, smokeless tobacco excluding snus pouches, or dissolvable tobacco.

c

Includes use of cigars as blunts.

d

Includes non-prescribed Ritalin/Adderall, non-prescribed painkillers/sedatives, cocaine and other stimulants, heroin, inhalants, solvents, and hallucinogens.

e

Includes use of two or more substances (tobacco, alcohol, marijuana, and other drugs).

f

Includes use of two or more substances (alcohol, marijuana, and other drugs).

g

n represents unweighted sample sizes.

h

Percents (%) and standard errors (SEs) represent weighted estimates.

i

Odds ratios (ORs) and 95% confidence intervals (CIs) from unadjusted logistic regression models.

j

Measured via the modified Brief Sensation Seeking Scale.

k

Includes non-Hispanic American Indian/Alaska Natives, Asian/Native Hawaiian/Other Pacific Islanders, or multiple races.

l

Assessed via the Global Appraisal of Individual Needs-Short Screener (GAIN-SS) subscales, categorized into no/low (0–2 symptoms), moderate severity (3–7 symptoms) and high severity (8–11 symptoms).

m

Academic performance was based on parents’ responses regarding their child’s (or self-reported in case of emancipated youth) grades at school in the past 12 months and categorized as at or above average (C grades and higher) and below average (below Cs).

n

Estimate should be interpreted with caution because it has low statistical precision. It is based on a denominator sample size of < 50, or the coefficient of variation of the estimate or its complement is larger than 30%.

Table 3 presents the associations between susceptibility to tobacco use and onset of any tobacco, alcohol, marijuana, and other drug use. Susceptibility to tobacco use was significantly associated with higher odds of onset of tobacco use (OR = 3.0; 95% CI: 2.3, 3.8), alcohol use (OR = 1.8; 95% CI: 1.5, 2.2), and marijuana use (OR = 3.4; 95% CI: 2.4, 4.8) after adjusting for demographics, academic performance, sensation seeking, tobacco product user in the household, receptivity to tobacco product advertising, and lifetime mental health problems. No significant association was observed between susceptibility to tobacco use and onset of other drug use.

Table 3.

Susceptibility to tobacco use and onset of tobacco, alcohol, marijuana, and other drug use among W1 youth never substance users (n = 5325).

Wave 2
Onset of tobacco usea Onset of alcohol use Onset of marijuana useb Onset of other drug usec




Wave 1 nd %e SEe ORf 95% CIf nd %e SEe ORf 95% CIf nd %e SEe ORf 95% CIf nd %e SEe ORf 95% CIf
Total 504 9.4 0.5 668 12.9 0.6 229 4.1 0.3 290 5.3 0.3
Unadjusted model
Susceptibility to tobacco useg
 No 202 5.4 0.4 Referent 352 10.0 0.6 Referent 79 2.0 0.2 Referent 187 5.0 0.4 Referent
 Yes 302 18.1 1.1 3.8 3.0 4.9 316 19.2 1.2 2.1 1.8 2.6 150 8.8 0.8 4.7 3.5 6.3 103 6.0 0.7 1.2 0.9 1.6
Adjusted modelh
Susceptibility to tobacco useg
 No 202 5.4 0.4 Referent 352 10.0 0.6 Referent 79 2.0 0.2 Referent 187 5.0 0.4 Referent
 Yes 302 18.1 1.1 3.0 2.3 3.8 316 19.2 1.2 1.8 1.5 2.2 150 8.8 0.8 3.4 2.4 4.8 103 6.0 0.7 1.0 0.7 1.4

Statistically significant associations at p < .05 indicated in bold text.

a

Refers to cigarettes, e-cigarettes, traditional cigars, cigarillos, filtered cigars, pipe, hookah, snus pouches, smokeless tobacco excluding snus pouches, or dissolvable tobacco.

b

Includes use of cigars as blunts.

c

Includes non-prescribed Ritalin/Adderall, non-prescribed painkillers/sedatives, cocaine and other stimulants, heroin, inhalants, solvents, and hallucinogens.

d

n represents unweighted sample sizes.

e

Percents (%) and standard errors (SEs) represent weighted estimates.

f

Odds ratios (ORs) and 95% confidence intervals (CIs) from logistic regression models.

g

Defined as the strongest rejection to questions regarding curiosity about tobacco products, intention not to use tobacco products, and resistance of an offer to use tobacco products from a best friend.

h

Adjusted for age, sex, race/ethnicity, academic performance, sensation seeking, tobacco product user in household, receptivity to tobacco product advertising, and lifetime mental health problems at Wave 1.

Table 4 presents the association between susceptibility to tobacco use and the 7-category onset of substance use variable. In adjusted models (bottom portion of Table 3), tobacco-susceptible youth at W1 compared with those not susceptible to tobacco use, had higher odds of onset of exclusive tobacco use (AOR = 2.4; 95% CI: 1.7, 3.3), exclusive alcohol use (AOR = 1.5; 95% CI: 1.2, 1.8), and polysubstance (including [AOR = 3.9; 95% CI: 2.8, 5.6] and excluding [AOR = 1.8; 95% CI: 1.1, 3.0] tobacco) use at W2 compared with W2 never substance use. Results from the unadjusted models (top portion of Table 4) were largely consistent with the adjusted models, with two differences. First, and not surprisingly, the magnitude of the odds ratios is larger in the unadjusted models. Second, the association between susceptibility to tobacco use and the onset of exclusive marijuana use was significant only in the unadjusted model.

Table 4.

Susceptibility to tobacco use and substance use onset among W1 youth never substance users (n = 5325).

Wave 2
Onset of substance use
Never usea Exclusive tobacco useb Exclusive alcohol use Exclusive marijuana usec




Wave 1 ng %h SEh ng %h SEh ORi 95% CIi ng %h SEh ORi 95% CIi ng %h SEh ORi
Total 4090 77.0 0.7 246 4.4 0.3 422 8.2 0.4 53 0.9 0.1
Unadjusted model
Susceptibility to tobacco usej
 No 2956 81.9 0.8 113 3.0 0.3 Referent 255 7.3 0.5 Referent 29 0.7 0.1 Referent
 Yes 1134 66.2 1.3 133 7.4 0.6 3.1 2.3 4.1 167 10.1 0.8 1.7 2.1 24 1.2 0.3 2.1
Adjusted modelk
Susceptibility to tobacco usej
 No 2956 81.9 0.8 113 3.0 0.3 Referent 255 7.3 0.5 Referent 29 0.7 0.1 Referent
 Yes 1134 66.2 1.3 133 7.4 0.6 2.4 1.7 3.3 167 10.1 0.8 1.5 1.8 24 1.2 0.3 1.6
Wave 2
Onset of substance use
Exclusive
marijuana usec
Exclusive other drug used Poly-substance including tobacco usee Poly-substance excluding tobacco usef




Wave 1 95% CIi ng %h SEh ORi 95% CIi ng %h SEh ORi 95% CIi ng %h SEh ORi 95% CIi
Total 174 3.1 0.3 258 5.0 0.4 82 1.4 0.2
Unadjusted model
Susceptibility to tobacco usej
 No Referent 131 3.5 0.3 Referent 89 2.5 0.3 Referent 43 1.2 0.2 Referent
 Yes 1.1 4.0 43 2.4 0.4 0.9 0.6 1.3 169 10.7 1.1 5.4 3.9 7.5 39 2.0 0.4 2.2 1.3 3.6
Adjusted modelk
Susceptibility to tobacco usej
 No Referent 131 3.5 0.3 Referent 89 2.5 0.3 Referent 43 1.2 0.2 Referent
No
 Yes 0.8 3.1 43 2.4 0.4 0.8 0.5 1.2 169 10.7 1.1 3.9 2.8 5.6 39 2.0 0.4 1.8 1.1 3.0

Statistically significant associations at p < .05 indicated in bold text.

a

Reference group.

b

Refers to cigarettes, e-cigarettes, traditional cigars, cigarillos, filtered cigars, pipe, hookah, snus pouches, smokeless tobacco excluding snus pouches, or dissolvable tobacco.

c

Includes use of cigars as blunts.

d

Includes non-prescribed Ritalin/Adderall, non-prescribed painkillers/sedatives, cocaine and other stimulants, heroin, inhalants, solvents, and hallucinogens.

e

Includes use of two or more substances (tobacco, alcohol, marijuana, and other drugs).

f

Includes use of two or more substances (alcohol, marijuana, and other drugs).

g

n represents unweighted sample sizes.

h

Percents (%) and standard errors (SEs) represent weighted estimates.

i

Odds ratios (ORs) and 95% confidence intervals (CIs) from multinomial logistic regression models.

j

Defined as the strongest rejection to questions regarding curiosity about tobacco products, intention not to use tobacco products, and resistance of an offer to use tobacco products from a best friend.

k

Adjusted for age, sex, race/ethnicity, academic performance, sensation seeking, tobacco product user in household, receptivity to tobacco product advertising, and lifetime mental health problems at Wave 1.

4. Discussion

Consistent with prior studies that focused on specific tobacco products (Nicksic and Barnes, 2019; Nodora et al., 2014; Pierce et al., 1996; Pierce et al., 2018), susceptibility to tobacco use was associated with the onset of tobacco use both for exclusive tobacco use and for polysubstance use including tobacco. Importantly, our findings extend susceptibility to tobacco use as a predictor of the onset of use of substances other than tobacco products. A prior PATH Study analysis showed significant associations between e-cigarette susceptibility and onset of alcohol and marijuana use a year later (Nicksic and Barnes, 2019), and our study expanded these findings to susceptibility to any tobacco use beyond e-cigarettes. Moreover, because youth who use alcohol and drugs tend to also use tobacco products, we examined onset of substance use as seven mutually exclusive categories and found that susceptibility to tobacco use predicted the onset of exclusive tobacco use, exclusive alcohol use, and polysubstance use (including and excluding tobacco).

Susceptibility to tobacco use was not significantly associated with the onset of exclusive marijuana use; this suggests that the association between susceptibility to tobacco use and onset of marijuana use may be driven by polysubstance use in youth marijuana users. However, the low incidence of exclusive marijuana use limited our ability to detect an association with a small effect, though it is consistent with previous research finding relative rarity of exclusive marijuana use in youth (Han et al., 2017). Future studies can examine this heterogeneity in youth marijuana users based on their use of other substances including tobacco products. Additionally, susceptibility to tobacco use was not significantly associated with exclusive other drug use (i.e. non-prescribed use of Ritalin® or Adderall®, painkillers, sedatives, or tranquilizers, and cocaine or crack, other stimulants [i.e. methamphetamine or speed], heroin, inhalants, solvents, and hallucinogens); this again implicates other risk factors for youth who initiate exclusively with these substances. Although relatively few youth (3%) who had never previously used substances exclusively initiated other drug use, it is worth noting that non-prescribed painkillers were the predominant substance used by this group (used by > 90%). Importantly, lifetime mental health problems and receptivity to tobacco advertising were the only covariates associated with onset of exclusive other drug use relative to never substance use. That other traditional risk factors for substance use onset (e.g. age, sex, race/ethnicity, and academic performance) were not associated with this group warrants further exploration of this unique group of youth substance users and highlights the need for tailored intervention approaches. Finally, that susceptibility to tobacco use predicted the onset of exclusive alcohol use and polysubstance use with or without tobacco use supports our hypothesis that susceptibility to tobacco use can be used to predict substance use in general and may be a marker of vulnerability to any substance use.

Our findings have important implications for substance use prevention. The propensity of overall substance use is likely driven by shared susceptibility to tobacco, alcohol, and drug use possibly originating from genetic vulnerabilities or environmental factors such as access to substances and opportunities to use that govern cognitions, intentions, and peer influence on substance use onset (Vanyukov and Ridenour, 2012; Vanyukov et al., 2012). Our findings were robust to adjustment for several risk factors for tobacco and other substance use such as sensation seeking, tobacco product user in household, receptivity to tobacco product advertising, and lifetime mental health problems. While each of these covariates is an indicator for some source of common variance, future studies can examine shared genetic or environmental factors driving the propensity of overall substance use. Identifying and targeting youth at risk for substance use onset early in this critical developmental period can prevent progression from susceptibility to experimentation. Although various substance use prevention models exist that incorporate relevant risk factors associated with substance use onset (Botvin, 2000; Corbett, 2001; Griffin and Botvin, 2010; Griffin et al., 2003), integrating susceptibility to tobacco use as a potential screening tool to identify youth at risk of substance use may strengthen these prevention measures.

4.1. Study limitations and strengths

Our findings should be interpreted within the context of a few limitations. The PATH Study did not collect information on susceptibility per se to alcohol, marijuana, and other drug use, and therefore its effect on our results is unknown. Information on social norms and peer and family influences on tobacco and other substance use was also not available in the PATH Study. Additionally, the self-reported data are subject to misclassification. Nevertheless, this study is the first to prospectively show that susceptibility to tobacco use can be extended to predict the onset of substance use besides tobacco in a nationally representative sample of U.S. youth never users of any substance. Thus, as an early risk indicator, the short susceptibility scale of Pierce et al. might show even greater promise for substance use prevention.

5. Conclusions

Susceptibility to tobacco use significantly predicts tobacco use onset as well as onset of exclusive alcohol and polysubstance use among American youth. To maximize success, substance use prevention programs should target youth prior to them becoming susceptible and develop strategies based on the shared cognitions, intentions, and peer influences that prevail in tobacco-susceptible youth. The simple 3-question index may be one way to quickly identify youth at risk for initiating the use of addictive substances.

Acknowledgements

The authors would like to thank Dr. Ning Rui for his role in re-viewing the statistical programs and verifying the accuracy of the results presented in this manuscript.

Funding

This study was supported with federal funds from the National Institute on Drug Abuse (NIDA), National Institutes of Health, and the Center for Tobacco Products, the Food and Drug Administration (FDA), Department of Health and Human Services, under a contract to Westat (Contract No. HHSN271201100027C). Staff from the NIDA and the FDA contributed to the design, conduct, and management of the PATH Study. The NIDA and the FDA were not directly involved in the collection of study data. No funding was provided specifically for conducting the analysis, drafting the manuscript, or submitting this paper for publication.

Financial disclosure

Dr. Compton reports long-term stock holdings in General Electric Co., 3M Companies and Pfizer, Inc. unrelated to this manuscript. Other authors have no financial relationships relevant to this article to disclose.

Footnotes

Disclaimer

The views and opinions expressed in this manuscript are those of the authors only and do not necessarily represent the views, official policy or position of the U.S. Department of Health and Human Services or any of its affiliated institutions or agencies. This article was prepared while Dr. Conway was employed at the National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD.

Declaration of competing interest

The authors have no conflicts of interest to disclose.

References

  1. Botvin GJ, 2000. Preventing drug abuse in schools: social and competence enhancement approaches targeting individual-level etiologic factors. Addict. Behav 25, 887–897. [DOI] [PubMed] [Google Scholar]
  2. Centers for Disease Control and Prevention (CDC), 2011. –2012. National Health and Nutrition Examination Survey Questionnaire (NHANES) in: National Center for Health Statistics; (Hyattsville, MD: ). [Google Scholar]
  3. Conway KP, Green VR, Kasza KA, Silveira ML, Borek N, Kimmel HL, Sargent JD, Stanton CA, Lambert E, et al. , 2018. Co-occurrence of tobacco product use, substance use, and mental health problems among youth: findings from wave 1 (2013–2014) of the population assessment of tobacco and health (PATH) study. Addict. Behav 76, 208–217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Corbett KK, 2001. Susceptibility of youth to tobacco: a social ecological framework for prevention. Respir. Physiol 128, 103–118. [DOI] [PubMed] [Google Scholar]
  5. Dennis ML, Chan YF, Funk RR, 2006. Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults. Am. J. Addict 15 (Suppl. 1), 80–91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Green VR, Conway KP, Silveira ML, Kasza KA, Cohn A, Cummings KM, Stanton CA, Callahan-Lyon P, Slavit W, et al. , 2018. Mental health problems and onset of tobacco use among 12- to 24-year-olds in the PATH study. Journal of the American Academy of Child and Adolescent Psychiatry 57, 944–954.e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Griffin KW, Botvin GJ, 2010. Evidence-based interventions for preventing substance use disorders in adolescents. Child Adolesc. Psychiatr. Clin. N. Am 19, 505–526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Griffin KW, Botvin GJ, Nichols TR, Doyle MM, 2003. Effectiveness of a universal drug abuse prevention approach for youth at high risk for substance use initiation. Prev. Med 36, 1–7. [DOI] [PubMed] [Google Scholar]
  9. Hall WD, Patton G, Stockings E, Weier M, Lynskey M, Morley KI, Degenhardt L, 2016. Why young people’s substance use matters for global health. Lancet Psychiatry 3, 265–279. [DOI] [PubMed] [Google Scholar]
  10. Han B, Compton WM, Blanco C, DuPont RL, 2017. National trends in substance use and use disorders among youth. J Am Acad Child Adolesc Psychiatry 56, 747–754.e3. [DOI] [PubMed] [Google Scholar]
  11. Hoyle RH, Stephenson MT, Palmgreen P, Lorch EP, Donohew RL, 2002. Reliability and validity of a brief measure of sensation seeking. Personal. Individ. Differ 32, 401–414. [Google Scholar]
  12. Hyland A, Ambrose BK, Conway KP, Borek N, Lambert E, Carusi C, Taylor K, Crosse S, Fong GT, et al. , 2017. Design and methods of the population assessment of tobacco and health (PATH) study. Tob. Control 26, 371–378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Jessor R, 1991. Risk behavior in adolescence: a psychosocial framework for under-standing and action. J. Adolesc. Health 12, 597–605. [DOI] [PubMed] [Google Scholar]
  14. Judkins DR, 1990. Fay’s method for variance estimation. J. Off. Stat 6, 223–239. [Google Scholar]
  15. Klein RJ, Proctor SE, Boudreault MA, Turczyn KM, 2002. Healthy People 2010 Criteria for Data Suppression, Statistical Notes, No. 24, 2002/07/16 ed. National Center for Health Statistics, Hyattsville, Maryland, pp. 1–12. [PubMed] [Google Scholar]
  16. McCarthy PJ, 1969. Pseudoreplication: further evaluation and applications of the balanced half-sample technique. Vital Health Stat 2, 1–24. [PubMed] [Google Scholar]
  17. National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2012. Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. Centers for Disease Control and Prevention (US), Atlanta (GA). [PubMed] [Google Scholar]
  18. National Institutes of Health (NIH), 2004. –2005. National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). in: National Institute on Alcohol Abuse and Alcoholism (NIAAA) (Rockville, MD: ). [Google Scholar]
  19. Nicksic NE, Barnes AJ, 2019. Is susceptibility to E-cigarettes among youth associated with tobacco and other substance use behaviors one year later? Results from the PATH study. Prev. Med 121, 109–114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nodora J, Hartman SJ, Strong DR, Messer K, Vera LE, White MM, Portnoy DB, Choiniere CJ, Vullo GC, et al. , 2014. Curiosity predicts smoking experimentation independent of susceptibility in a US national sample. Addict. Behav 39, 1695–1700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pierce JP, Choi WS, Gilpin EA, Farkas AJ, Merritt RK, 1996. Validation of susceptibility as a predictor of which adolescents take up smoking in the United States. Health Psychol. 15, 355–361. [DOI] [PubMed] [Google Scholar]
  22. Pierce JP, Sargent JD, White MM, Borek N, Portnoy DB, Green VR, Kaufman AR, Stanton CA, Bansal-Travers M, et al. , 2017. Receptivity to tobacco advertising and susceptibility to tobacco products. Pediatrics 139, e20163353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pierce JP, Sargent JD, Portnoy DB, White M, Noble M, Kealey S, Borek N, Carusi C, Choi K, et al. , 2018. Association between receptivity to tobacco advertising and progression to tobacco use in youth and young adults in the PATH study. JAMA Pediatr. 172, 444–451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Richter L, Pugh BS, Smith PH, Ball SA, 2017. The co-occurrence of nicotine and other substance use and addiction among youth and adults in the United States: implications for research, practice, and policy. Am. J. Drug Alcohol Abuse 43, 132–145. [DOI] [PubMed] [Google Scholar]
  25. Silveira ML, Conway KP, Green VR, Kasza KA, Sargent JD, Borek N, Stanton CA, Cohn A, Hilmi N, et al. , 2018. Longitudinal associations between youth tobacco and substance use in waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study. Drug Alcohol Depend. 191, 25–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Silveira ML, Green VR, Iannaccone R, Kimmel HL, Conway KP, 2019. Patterns and correlates of poly-substance use among U.S. youth ages 15–17 years: Wave 1 of the population assessment of tobacco and health (PATH) study. Addiction (Abingdon, England) 114 (5), 907–916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Stone AL, Becker LG, Huber AM, Catalano RF, 2012. Review of risk and protective factors of substance use and problem use in emerging adulthood. Addict. Behav 37, 747–775. [DOI] [PubMed] [Google Scholar]
  28. Strong DR, Hartman SJ, Nodora J, Messer K, James L, White M, Portnoy DB, Choiniere CJ, Vullo GC, et al. , 2015. Predictive validity of the expanded susceptibility to smoke index. Nicotine Tob. Res 17, 862–869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tomczyk S, Isensee B, Hanewinkel R, 2016. Latent classes of polysubstance use among adolescents-a systematic review. Drug Alcohol Depend. 160, 12–29. [DOI] [PubMed] [Google Scholar]
  30. Trinidad DR, Pierce JP, Sargent JD, White MM, Strong DR, Portnoy DB, Green VR, Stanton CA, Choi K, et al. , 2017. Susceptibility to tobacco product use among youth in wave 1 of the Population Assessment of Tobacco and Health (PATH) Study. Prev. Med 101, 8–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. U.S. Department of Health and Human Services (HHS), Office of the Surgeon General, 2016. Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health. HHS, Washington, DC. [PubMed] [Google Scholar]
  32. United States Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, and United States Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Products., 2020. Population Assessment of Tobacco and Health (PATH) Study [United States] Restricted-Use Files Inter-university Consortium for Political and Social Research [distributor], Ann Arbor, MI: 10.3886/ICPSR36231.v23. [DOI] [Google Scholar]
  33. Vanyukov MM, Ridenour TA, 2012. Common liability to drug addictions: theory, research, practice. Drug Alcohol Depend. 123 (Suppl. 1), S1–S2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Vanyukov MM, Tarter RE, Kirillova GP, Kirisci L, Reynolds MD, Kreek MJ, Conway KP, Maher BS, Iacono WG, et al. , 2012. Common liability to addiction and “gateway hypothesis”: theoretical, empirical and evolutionary perspective. Drug Alcohol Depend. 123 (Suppl. 1), S3–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wellman RJ, Dugas EN, Dutczak H, O’Loughlin EK, Datta GD, Lauzon B, O’Loughlin J, 2016. Predictors of the onset of cigarette smoking: a systematic review of longitudinal population-based studies in youth. Am. J. Prev. Med 51, 767–778. [DOI] [PubMed] [Google Scholar]

RESOURCES